Author:
Wei L.,Sun L.-Q.,Zhang C.-Y.,Tang X.-Q.,Wang F. Q.,Wang K.-C.,Yang J.
Reference37 articles.
1. National Pharmacopoeia Commission, Pharmacopoeia of the People’s Republic of China 2020, Beijing: China Medical Science and Technology Press, 2020.
2. Meijer, L., Shearer, J., Bettayeb, K., and Ferandin, Y., Diversity of intracellular mechanisms underlying the anti-tumor properties of indirubins, Int. Congr. Ser., 2007, vol. 1304, p. 60. https://doi.org/10.1016/j.ics.2007.07.041
3. Wang, H.Z., Wang, Z.Y., Wei, C.Y., Wang, J., Xu, Y.S., Bai, G.H., Yao, Q.Z., Zhang, L., and Chen, Y.Z., Anticancer potential of indirubins in medicinal chemistry: Biological activity, structural modification, and structure-activity relationship, Eur. J. Med. Chem., 2021, vol. 223, p. 113652. https://doi.org/10.1016/j.ejmech.2021.113652
4. Zhou, W. and Zhang, X.Y., Research progress of Chinese herbal medicine Radix
isatidis (Banlangen), Am. J. Chin. Med., 2013, vol. 41, p. 743. https://doi.org/10.1142/s0192415x1350050x
5. Ye, M., Luo, G., Ye, D., She, M., and Zheng, J., Network pharmacology, molecular docking integrated surface plasmon resonance technology reveals the mechanism of Toujie Quwen Granules against coronavirus disease 2019 pneumonia, Phytomedicine, 2020, vol. 85, p. 153401. https://doi.org/10.1016/j.phymed.2020.153401